Open Access Journals

AIMS Neuroscience, 2015, 2(4): 240-258. doi: 10.3934/Neuroscience.2015.4.240. Research article

Export file:

Format

RIS(for EndNote,Reference Manager,ProCite)
BibTex
Text

Content

Citation Only
Citation and Abstract

Is Alzheimers Disease Infectious?
Relative to the CJD Bacterial Infection Model of Neurodegeneration

Department of Animal Science, Louisiana State University Agricultural Center 111 Dalrymple Building, Baton Rouge, LA 70803, USA

Received date: , Accepted date: , Published date:

Abstract Full Text(HTML) Figure/Table Related pages

Alzheimer's disease (AD) has been recently considered as a possible brain infection related to the Creutzfeldt-Jakob disease (CJD) transmissible dementia model. As with CJD, there is controversy whether the infectious agent is an amyloid protein (prion theory) or a bacterium. In this review, we show that the prion theory lacks credibility because spiroplasma, a tiny wall-less bacterium, is clearly involved in the pathogenesis of CJD and the prion amyloid can be separated from infectivity. In addition to prion amyloid deposits, the transmissible agent of CJD is associated with amyloids (A-β, Tau, and α-synuclein) characteristic of other neurodegenerative diseases including AD and Parkinsonism. Reports of spiroplasma inducing formation of α-synuclein in tissue culture and Borrelia spirochetes inducing formation of A-β and Tau in tissue culture suggests that bacteria may have a role in the pathogenesis of the neurodegenerative diseases.

Figure/Table

Supplementary

Article Metrics

Keywords: spiroplasma; Alzheimer's disease; prion; A-β; α-synuclein; prion, bacteria; Parkinson's disease; neurodegenerative disease; amyloid

Citation: Frank O. Bastian. Is Alzheimers Disease Infectious?
Relative to the CJD Bacterial Infection Model of Neurodegeneration. AIMS Neuroscience, 2015, 2(4): 240-258. doi: 10.3934/Neuroscience.2015.4.240

References:

1. Stoeck K, Schmitz M, Ebert E, et al. (2014) Immune responses in rapidly progressive dementia: a comparative study of neuroinflammatory markers in Creutzfeldt-Jakob disease, Alzheimer's disease and multiple sclerosis. J Neuroinflam 11: 170-178.
2. Kojima G, Tatsuno BK, Inaba M, et al. (2013) Creutzfeldt-Jakob disease: a case report and differential diagnosis. Hawai'i J Med Public Health 72: 136-139.
3. Manuelidis EE, Manuelidis L (1989) A clinical series with 13% of Alzheimer's disease actually CJD. Alz Dis Assoc Disorders 3: 100-109.
4. Bastian FO, McDermont ME, Perry AS, et al. (2005) Safe method for isolation of prion protein and diagnosis of Creutzfeldt-Jakob disease. J Virol Methods 130: 133-139.
5. Nicolson GI (2008) Chronic bacterial and viral infections in neurodegenerative and neurobehavioral diseases. Lab Med 39: 291-299.
6. Bastian FO (1991) Author, Creutzfeldt-Jakob Disease and Other Transmissible Spongiform Encephalopathies, New York, Mosby/Year Book 256 pp
7. Matthews WB (1978) Creutzfeldt-Jakob disease. Postgrad Med J 54: 591-594.
8. Manuelidis EE, De Figuriredo JM, Kim JH, et al. (1988) Transmission studies from blood of Azheimer disease patients and healthy relatives. Proc Natl Acad Sci (USA) 85: 4898-4901.
9. Manuelidis EE, Gorgacz EJ, Manuelidis L (1978) Transmission of Creutzfeldt-Jakob disease with scrapie-like syndromes to mice. Nature 271: 778-779.
10. Hainfellner JA, Wanschitz J, Jellinger K, et al. (1998) Coexistence of Alzheimer-type neuropathology in Creutzfeldt_Jakob disease. Acta Neuropathol 96: 116-122.
11. Solito E, Sastre M (2012) Microglia function in Alzheimer's disease. Frontiers Pharmacol 3: 1-10.
12. Tousseyn T, Bajsarowicz K, Sanchez H, et al. (2015) Prion disease induces Alzheimer disease-like neuropathologic changes. J Neuropathol Exp Neurol 74: 873-888.
13. Dheen ST, Kaur C, Ling EA (2007) Microglial activation and its implications in the brain diseases. Current Med Chem 14: 1189-1197.
14. Mattson MP (2002) Oxidative stress, perturbed calcium homeostasis, and immune dysfunction in Alzheimer's disease. J Neurovirol 8: 539-550.
15. Garcao P, Oliveira CR, Agostinho P (2006) Comparative study of microglia activation induced by amyloid-β and prion peptides. J Neurosci Res 84: 182-193.
16. Lee DY, Lee J, Sugden B (2009) The unfolded protein response and autophagy: herpes viruses rule! J Virol 83: 1168-1172.
17. Unterberger U, Hoftberger R, Gelpi E, et al. (2006) Endoplasmic reticulum stress features are prominent in Alzheimer's disease but not in prion disease in vivo. J Neuropathol Exp Neurol 65: 348-357.
18. Sorce S, Nuvolone M, Keller A, et al. (2014) The role of NADPH oxidase NOX2 in prion pathogenesis. PLoS Pathogens 10: e1004531.
19. Bastian FO (2014) Cross-roads in research on neurodegenerative diseases. J Alzheimer's Dis Parkinsonism 4: 141. doi:10.4172/21610460.1000141.
20. Moreno JA, Radford H, Peretti D, et al. (2012) Sustained translational repression of eIF2α mediates prion neurodegeneration. Nature 485: 507-511.
21. Greenlee JJ, Greenlee MH (2015) The transmissible spongiform encephalopathies of livestock. Ilar J 56: 7-25.
22. Baker CA, Martin D, Manuelidis L (2002) Microglia from Creutzfeldt-Jakob disease-infected brains are infectious and show specific mRNA activation profiles. J Virol 76: 10905-10913.
23. Murali A, Maue RA, Dolph PJ (2014) Reversible symptoms and clearance of mutant prion protein in an inducible model of a genetic prion disease in Drosophilia melanogaster. Neurobiol Dis 67: 71-78.
24. Sala I, Marquie M, Sanchez-Saudinos MB, et al. (2012) Rapidy progressive dementia: experience in a tertiary care medical center. Alzheimer Dis Assoc Disorders 26: 267-271.
25. Armitage WJ, Tullo AB, Ironside JW (2009) Risk of Creutzfeldt-Jakob disease transmission by ocular surgery and tissue transplantation. Eye 23: 1926-1930.
26. Wemheuer WM, Benestad SL, Wrede A, et al. (2009) Similarities between forms of sheep scrapie and Creutzfeldt-Jakob disease are encoded by distinct prion types. Amer J Pathol 175: 2566-2573.
27. Cassard H, Torres JM, Lacroux C, et al. (2014) Evidence for zoonotic potential of ovine scrapie prions. Nature communications 5: 5821 doi:10.1038/ncomms6821.
28. Merz PA, Somerville RA, Wisniewski HM, et al. (1983) Scrapie-associated fibrils in Creutzfeldt-Jakob disease. Nature 306: 474-476.
29. Wisniewski T, Aucouturier P, Soto C, et al. (1998) The prionoses and other conformational disorders. Amyloid 5: 212-224.
30. Serrano-Pozo A, Frosch MP, Masliah E, et al. (2011) Neuropathological alterations in Alzheimer Disease. Cold Spring Harb Perspect Med 1: a006189.
31. Kessels HW, Nguyen LN, Nabavi S, et al. (2010) The prion protein as a receptor for amyloid-β. Nature 466: 7308 E3-4.
32. Kumar A, Pate KM, Moss MA, et al. (2014) Self-propagative replication of A-β oligomers suggests potential transmissibility in Alzheimer disease. PLoS ONE 9: e111492.
33. Guo JL, Lee VM (2011) Seeding of normal Tau by pathological Tau conformers drives pathogenesis of Alzheimer-like tangles. J Biol Chem 286: 15317-15331.
34. Liu L, Drouet V, Wu JW, et al. (2012) Trans-synaptic spread of Tau pathology in vivo. PloS ONE 7: e31302. Doi:10.1371.
35. Eisele YS, Bolmont T, Heikenwalder M, et al. (2009) Induction of cerebral β-amyloidosis: intracerebral versus systemic Aβ inoculation. PNAS 106: 12926-12931.
36. Morales R, Duran-Aniotz C, Castilla J, et al. (2011) De novo induction of amyloid-β deposition in vivo. Mol Psychiatry 17: 1347-1353.
37. Volpicelli-Daley LA, Luk KC, Patel TP, et al. (2011) Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72: 57-71.
38. Luk KC, Kehm VM, Zhang B, et al. (2012) Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice. J Exp Med 209: 975-986.
39. Stöhr J, Watts JC, Mensinger ZL, et al. Purified and synthetic Alzheimer's amyloid β (Aβ) prions. PNAS 109: 11025-11030.
40. Ghoshal N, Cali I, Perrin RJ, et al. (2009) Co-distribution of amyloid β plaques and spongiform degeneration in familial Creutzfeldt-Jakob disease with the E200K-129M haplotype. Arch Neurol 66: 1240-1246.
41. Salvadores N, Shahnawaz M, Scarpini E, et al. (2014) Detection of misfolded Aβ oligonmers for sensitive biochemical diagnosis of Alzheimer's disease. Cell Reports 7: 261-268.
42. Morales R, Moreno-Gonzalez I, Soto C (2013) Cross-seeding of misfolded proteins: implications for etiology and pathogenesis of protein misfolding diseases. PLOS 9: e1003537.
43. Chi EY, Frey SL, Winans A, et al. (2010) Amyloid-β fibrillogenesis seeded by interface-induced peptide misfolding and self-assembly. Biophy J 98: 2299-2308.
44. Tateishi J, Kitamoto T, Hoque MZ, et al. (1996) Experimental transmission of Creutzfeldt-Jakob disease and related diseases to rodents. Neurology 46: 532-537.
45. Kovacs GG, Seguin J, Quadrio I, et al. (2011) Genetic Creutzfeldt-Jakob disease associated with the E200K mutation: characterization of a complex proteinopathy. Acta Neuropathologica 121: 39-57.
46. Vital A, Canron M-H, Gil R, et al. (2007) A sporadic case of Creutzfeldt-Jakob disease with β-amyloid deposits and α-synuclein inclusions. Neuropathology 27: 273-277.
47. Kasai T, Tokuda T, Ishii R, et al. (2014) Increased α-synuclein levels in the cerebrospinal fluid of patients with Creutzfeldt–Jakob disease. J Neurol 261: 7334-7337.
48. Zhang M, Hu R, Chen H, et al. (2015) Polymorphic cross-seeding amyloid assemblies of amyloid-β and human islet amyloid peptide. Phys Chem Chem Phys 17: 23245-23256.
49. O'Nuallain B, Williams AD, Westermark P, et al. (2004) Seeding specificity in amyloid growth induced by heterologous fibrils. J Biol Chem 279: 17490-17499.
50. Westermark P, Westermark GT (2013) Seeding and cross-seeding in amyloid diseases, in Zucker M, Christen Y (eds.) Proteopathic Seeds and Neurodegenerative Diseases, Research and Perspectives in Alzheimer' Disease, Berlin, Springer-Verlag pp. 47-60.
51. Zhou Y, Smith D, Leong BJ, et al. (2012) Promiscuous cross-seeding between bacterial amyloids promotes interspecies biofilms. J Biol Chem 287: 35092-35103.
52. Prusiner SB (1987) Prions causing degenerative neurological diseases. Ann Rev Med 38: 381-398.
53. Vila-Vicosa D, Campos SR, Baptista AM, et al. (2012) Reversibility of prion misfolding: insights from constant –pH molecular dynamics simulations. J Physical Chem 116: 8812-8821.
54. Eisenberg D, Jucker M (2012) The amyloid state of proteins in human diseases. Cell 148: 1188-1203.
55. Mayer RJ, Landon M, Laszlo L, et al. (1992) Protein processing in lysosomes: the new therapeutic target in neurodegenerative disease. Lancet 340: 156-159.
56. Rigter A, Priem J, Langeveld JP, et al. (2011) Prion protein self-interaction in prion disease therapy approaches. Vet Quarterly 31: 115-128.
57. Safar JG (2012) Molecular pathogenesis of sporadic prion diseases in man. Prion 6: 108-115.
58. Tuite MF, Cox BS (2003) Propagation of yeast prions. Nature Rev Mol Cell Biol 4: 878-890.
59. Bellinger-Kawahara C, Diener TO, McKinley MP, et al. (1987) Purified scrapie prions resist inactivation by procedures that hydrolyze, modify, or shear nucleic acids. Virology 160: 271-274.
60. Hearst JE (1981) Psoralen photochemistry and nucleic acid structure. J Investigative Dermatol 77: 39-44.
61. Miyazawa K, Kipkorir T, Tittman S, et al. (2012) Continuous production of prions after infectious particles are eliminated: implications for Alzheimer's disease. PLoS ONE 7: 1-8.
62. Sun R, Liu Y, Zhang H, et al. (2008) Quantitative recovery of scrapie agent with minimal protein from highly infectious cultures. Viral Immunol 21:293-302.
63. Soto C, Estrada L, Castilla J (2006) Amyloids, prions and the inherent infectious nature of misfolded protein aggregates. Trends Biochem Sci 31: 150-155.
64. Klingeborn M, Race B, Meade-White KD, et al. (2011) Lower specific infectivity of protease-resistant prion protein generated in cell-free reactions. PNAS 108: E1244-E1253.
65. Manuelidis L (2011) Nuclease resistant circular DNAs copurify with infectivity in scrapie and CJD. J Neurovirol 17: 131-145.
66. Sonati T, Reimann RR, Falsig J, et al. (2013) The toxicity of antiprion antibodies is mediated by the flexible tail of the prion protein. Nature 501: 102-106.
67. Miyazawa K, Emmerling K, Manuelidis L (2011) Replication and spread of CJD, kuru and scrapie agents in vivo and in cell culture. Virulence 2: 188-199.
68. Watarai M, Kim S, Erdenebaatar J, et al. (2003) Cellular prion protein promotes Brucella infection into macrophages. J Exp Med 198: 5-17.
69. Bastian FO (2005) Spiroplasma as a candidate causal agent of transmissible spongiform encephalopathies. J Neuropathol Exp Neurol 64: 833-838.
70. Bastian FO (2014) The case for involvement of spiroplasma in the pathogenesis of transmissible spongiform encephalopathies. J Neuropathol Exp Neurol 73: 104-114.
71. Baker C, Martin D, Manuelidis L (2002) Microglia from Creutzfeldt-Jakob disease-infected brains are infectious and show specific mRNA activation profiles. J Virol 76: 10905-10913.
72. Marlatt MW, Bauer J, Aronica E, et al. (2014) Proliferation in the Alzheimer hippocampus is due to microglia, not astroglia, and occurs at sites of amyloid deposition. Neural Plasticity 2014: 693851 1-12.
73. Miklossy J, Kis A, Radenovic A, et al. (2006) Β-amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes. Neurobiol Aging 27: 228-236.
74. Balin BJ, Little CS, Hammond CJ, et al. (2008) Chlamydophila pneumonia and the etiology of late-onset Alzheimer's disease. J Alzheimer's Dis 13: 371-380.
75. Poole S, Singhrao SK, Kesavalu L, et al. (2013) Determining the presence of peridontopathic virulence factors in short-term postmortem Alzheimer's disease brain tissue. J Alzheimer's Dis 36: 665-677.
76. Singhrao SK, Harding A, Poole S, et al. (2015) Porphyromonas gingivalis periodontal infection and it putative links with Alzheimer's disease. Mediators Inflam 2015: 137357.
77. Singhrao SK, Harding A, Simmons T, et al. (2014) Oral inflammation, tooth loss, risk factors, and association with progression of Alzheimer's disease. J Alzheimer's Dis 42: 723-737.
78. Miklossy J (2008) Chronic inflammation and amyloidogenesis in Alzheimer's disease- role of spirochetes. J Alzheimer's Dis 13: 381-391.
79. Friedland RP (2015) Mechanisms of molecular mimicry involving the microbiota in neurodegeneration. J Alzheimer's Dis 45: 349-362.
80. Little CS, Joyce TA, Hammond CJ, et al. (2014) Detection of bacterial antigens and Alzheimer's disease-like pathology in the central nervous system of BALB/c mice following intranasal infection with a laboratory isolate of Chlamydia pneumoniae. Frontiers Aging Neurosci 6: 304. doi: 10.3389/fnagi.2014.00304 1-9.
81. Goto S, Anbutsu H, Fukatsu T (2006) Asymmetrical interactions between Wolbachia and Spiroplasma endosymbionts coexisting in the same insect host. Applied Environmental Microbiol 72: 4805-4810.
82. Takahashi Y, Mihara H (2004) Construction of chemically and conformationally self-replicating system of amyloid-like fibrils. Bioorg Med Chem 12: 693-699.
83. Barnhart MM, Chapman MR (2006) Curli biogenesis and function. Annu Rev Microbiol 60: 131-147.
84. Wang X, Chapman MR (2008) Curli provide the template for understanding controlled amyloid propagation. Prion 2: 57-60.
85. Lundmark K, Westermark G, Olsen A, et al. (2005) Protein fibrils in nature can enhance amyloid protein A amyloidosis in mice: cross-seeding as a disease mechanism. PNAS 102: 6098-6102.
86. Bastian FO (1979) Spiroplasma-like inclusions in Creutzfeldt-Jakob disease. Arch Pathol Lab Med 103: 665-669.
87. Bastian FO, Hart MN, Cancilla PA (1981) Additional evidence of spiroplasma in Creutzfeldt-Jakob disease. Lancet 1: 660.
88. Gray A, Francis RJ, Scholtz CL (1980) Spiroplasma and Creutzfeldt-Jakob disease. Lancet 2, 660.
89. Reyes JM, Hoenig EM (1981) Intracellular spiral inclusions in cerebral cell processes in Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol 40: 1-8.
90. Alexeeva I, Elliott EJ, Rollins S, et al. (2006) Absence of spiroplasma or other bacterial 16s rRNA genes in brain tissue of hamsters with scrapie. J Clin Microbiol 44: 91-97.
91. Bastian FO, Dash S, Garry RF (2004) Linking chronic wasting disease to scrapie by comparison of Spiroplasma mirum ribosomal DNA sequences. Exp Mol Pathol 77: 49-56.
92. Bastian FO, Sanders DE, Forbes WA, et al. (2007) Spiroplasma spp. from transmissible spongiform encephalopathy brains or ticks induce spongiform encephalopathy in ruminants. J Med Microbiol 56: 1235-1242.
93. Bastian FO, Boudreaux CM, Hagius SD, et al. (2011) Spiroplasma found in the eyes of scrapie affected sheep. Vet Ophthalmol 14: 10-17.
94. Bastian FO, Purnell DM, Tully JG (1984) Neuropathology of spiroplasma infection in the rat brain. Am J Pathol 114: 496-514.
95. Tully JG, Bastian FO, Rose DL (1984) Localization and persistence of spiroplasmas in an experimental brain infection in suckling rats. Ann Microbiol (Paris) 135A: 111-117.
96. Bastian FO, Jennings R, Huff C (1987) Neurotropic Response of Spiroplasma mirum following peripheral inoculation in the rat. Ann Microbiol (Inst Pasteur) 138: 651-655.
97. Jeffrey M, Scott JR, Fraser H (1991) Scrapie inoculation of mice: light and electron microscopy of the superior colliculi. Acta Neuropathol 81: 562-571.
98. Trachtenberg S, Gilad R (2001) A bacterial linear motor: cellular and molecular organization of the contractile cytoskeleton of the helical bacterium Spiroplasma melliferum BC3. Mol Microbiol 41: 827-848.
99. Bastian FO, Jennings R, Gardner W (1987) Antiserum to scrapie associated fibril protein cross-reacts with Spiroplasma mirum fibril proteins. J Clin Microbiol 25: 2430-2431.
100. Bastian FO, Elzer PH, Wu X (2012) Spiroplasma spp. biofilm formation is instrumental for their role in the pathogenesis of plant, insect and animal diseases. Exp Mol Pathol 93: 116-128.
101. Forloni G, Iussich S, Awan T, et al. (2002) Tetracyclines affect prion infectivity. PNAS 99: 10849-10854.
102. Guo YJ, Han J, Yao HL, et al. (2007) Treatment of scrapie pathogen 263K with tetracycline partially abolishes protease-resistant activity in vitro and reduces infectivity in vivo. Biomed Environ Sci 20: 198-202.
103. Haig DA, Pattison IH (1967) In-vitro growth of pieces of brain from scrapie-affected mice. J Path Bact 93: 724-727.
104. Pattison IH (1969) Scrapie- a personal view. J Clin Pathol (Supp) 6: 110-114.
105. Sinclair SH, Rennoll-Bankert KE, Dumier JS (2014) Effector bottleneck: microbial reprogramming of parasitized host cell transcription by epigenetic remodeling of chromatin structure. Front Genetics 5: 274. doi: 10.3389/fgene.2014.00274 1-10.
106. Di Francesco A, Arosio B, Falconi A, et al. (2015) Global changes in DNA methylation in Alzheimer's disease peripheral blodd mononuclear cells. Brain Behav Immun 45: 139-144.
107. Drury JL, Chung WO (2015) DNA methylation differentially regulates cytokine secretion in gingival epithelia in response to bacterial challengs. Pathogens Dis 73: 1-6.
108. Cal H, Xie Y, Hu L, et al. (2013) Prion protein (PrPc) interacts with histone H3 confirmed by affinity chromatography. J Chromat Analytical Tech Biomed Life Sci 929: 40-44.
109. Derail M, Mill J, Lunnon K (2014) The mitochondrial epigenome: a role in Alzheimer's disease? Epigenomics 6: 665-675.
110. Choi HS, Choi YG, Shinn HY, et al. (2014) Dysfunction of mitochondrial dynamics in the brains of scrapie-infected mice. Biochem Biophys Res Comm 448: 157-162.
111. Razin S, Yogev D, Naot Y (1998) Molecular biology and pathogenicity of mycoplasmas. Microbiol Mol Biol Rev 62: 1094-1156.
112. Nur I, Szyf M, Razin A, et al. (1985) Procaryotic and eukaryotic traits of DNA methylation in spiroplasmas. J Bacteriol 164: 19-24.
113. Halfmann R, Lindquist S (2010) Epigenetics in the extreme: prions and the inheritance of environmentally acquired traits. Science 330: 629-632.
114. Bastian FO (2014) Cross-roads in research on neurodegenerative diseases. J Alzheimer's Dis Parkinsonism 4: 1000141.
115. Bleme H, Hamon M, Cossart P (2012) Epigenetics and bacterial infections. Cold Spring Harb Perspect Med 2: a010272.

show all references

Reader Comments

your name: * your email: *

Copyright Info: 2015, Frank O. Bastian, licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution Licese (http://creativecommons.org/licenses/by/4.0)

Download full text in PDF

Associated material

Metrics